SCIENTIFIC BACKGROUND

SERPINC1

Category:

SCIENTIFIC BACKGROUND

Antithrombin (also known as antithrombin III (ATIII)) is one of the most important factors of the coagulation system with anticoagulant activity. It belongs to the serine protease inhibitor family and is synthesized by hepatocytes. Antithrombin is encoded by the gene SERPINC1. The two most significant domains of the protein are the thrombin-binding domain and a specific domain for binding heparin. An antithrombin deficiency results in decreased inhibition of procoagulant factors. As a result, patients with hereditary antithrombin deficiency have up to a 50-fold increased risk of venous thrombosis. The mode of action of antithrombin is mainly based on the inhibition of thrombin. Other interaction partners involved in coagulation that are inactivated by complex formation are factor IXa, factor Xa, factor XIa, and factor XIIa. The inhibitory response is enhanced by a factor of at least 1,000 by the cofactor heparin or interaction with endothelial heparin sulfate. Therefore, the lack of efficacy of heparin therapy or the need for higher dosing may indicate antithrombin deficiency.

 

Antithrombin deficiency is usually inherited in an autosomal dominant manner since homozygous or combined heterozygous alterations in SERPINC1 are largely lethal in utero. The prevalence in the population is estimated to be 1:500 to 1:5,000. Based on functional and immunochemical antithrombin analyses, antithrombin deficiency is divided into two distinct types:

  • Type I: quantitative defect, reduced antithrombin as well as antithrombin activity (caused by a synthesis defect, e.g., deletion, insertion, or splice site variant)
  • Type II: qualitative defect, decreased antithrombin activity at normal plasma concentration (caused by a structural defect, e.g., amino acid exchange in the thrombin or heparin-binding domain)

 

Maintenance of adequate antithrombin activity of at least 70% of normal functional levels is essential to ensure effective inhibition of blood coagulation proteases. Typically, functional antithrombin levels are reduced to below 50% of normal due to type I or type II antithrombin deficiency. Risk factors that may intensify the effect of hereditary antithrombin deficiency include pregnancy, smoking, and contraceptive use. Genetic analysis of the SERPINC1 gene is strongly recommended when hereditary antithrombin deficiency is suspected, as a significant proportion of patients escape diagnosis by activity assays, and variants in SERPINC1 are detected in 80% of patients. In addition to the hereditary form, decreased antithrombin synthesis in the liver, e.g., due to liver cirrhosis, can lead to acquired antithrombin deficiency. Diseases such as nephrotic syndrome and disseminated intravascular coagulopathy can also lead to the reduction of antithrombin.

 

References

Mulder et al. 2017, Br. J. Haematol 178:279 / Zeng et al. 2015, Thromb Haemost 113.2:262 / Cooper et al. 2012, Semin Thromb Haemost 38:600 / de la Morena-Barrio et al. 2012, Thromb Haemost 107.3:430

GENES

SERPINC1

ASSOCIATED TESTS

How to order

LATEST ARTICLES

Traditional DNA tests may overlook 10% of classic in Familial Adenomatous Polyposis (FAP) cases. By integrating RNA sequencing, researchers unveiled ...

Read more

Overview In January 2024, the American Society of Clinical Oncology (ASCO) and the Society of Surgical Oncology (SSO) published new recommendation...

Read more

Endometriosis is a chronic gynecological condition that affects 1 in 10 women of reproductive age worldwide [1]. It can manifest with the first menst...

Read more

Rare Disease Day is a global awareness day held annually to raise awareness of all rare diseases. It was first celebrated in 2008, on the rarest day ...

Read more

Cancer is a group of genetic diseases that can develop almost anywhere in the body. Many people in the world are affected by cancer every year. Follo...

Read more

Aiming to evaluate the role of chromosomal aneuploidy in pregnancy loss, a 2023 study 35 years in the making evaluated the genomic landscape of first...

Read more

Cancer is a complex genetic disease that affects millions of people in the world. It is one of the leading causes of death worldwide, with about ten ...

Read more

Researchers created a detailed map of the placenta during labor. By studying how maternal and fetal cells communicate, they discovered signals in the...

Read more

A recent paper published in Nature Medicine (1) aimed to identify genes and genomic biomarkers which can better predict outcomes and personalized the...

Read more

In honor of the international day of women and girls in science, we interviewed one of our very own, Dr. Evelina Papaioannou. Dr. Evelina Pa...

Read more